RVNC INVESTOR ALERT: Kirby McInerney LLP Reminds Revance Therapeutics, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP notifies investors of the approaching March 4, 2025, deadline to seek the role of lead